List of Excipients in API guaifenesin, dextromethorphan hydrobromide
✉ Email this page to a colleague
Excipients in ANDA-approved (generic) drugs containing guaifenesin, dextromethorphan hydrobromide
Detailed excipient profiles for guaifenesin, dextromethorphan hydrobromide
Excipient focus: CARBOMER HOMOPOLYMER TYPE B
guaifenesin, dextromethorphan hydrobromide drug variants containing CARBOMER HOMOPOLYMER TYPE B
| Company | Ingredient | NDC |
|---|---|---|
| CVS Pharmacy | guaifenesin, dextromethorphan hydrobromide | 69842-963 |
| >Company | >Ingredient | >NDC |
guaifenesin, dextromethorphan hydrobromide drug variants not containing CARBOMER HOMOPOLYMER TYPE B
| Company | Ingredient | NDC |
|---|---|---|
| No data available in table | ||
| >Company | >Ingredient | >NDC |
Excipient focus: CELLULOSE, MICROCRYSTALLINE
guaifenesin, dextromethorphan hydrobromide drug variants containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| CVS Pharmacy | guaifenesin, dextromethorphan hydrobromide | 69842-963 |
| >Company | >Ingredient | >NDC |
guaifenesin, dextromethorphan hydrobromide drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| No data available in table | ||
| >Company | >Ingredient | >NDC |
Excipient focus: COPOVIDONE K25-31
guaifenesin, dextromethorphan hydrobromide drug variants containing COPOVIDONE K25-31
| Company | Ingredient | NDC |
|---|---|---|
| CVS Pharmacy | guaifenesin, dextromethorphan hydrobromide | 69842-963 |
| >Company | >Ingredient | >NDC |
guaifenesin, dextromethorphan hydrobromide drug variants not containing COPOVIDONE K25-31
| Company | Ingredient | NDC |
|---|---|---|
| No data available in table | ||
| >Company | >Ingredient | >NDC |
Excipient focus: D&C YELLOW NO. 10
guaifenesin, dextromethorphan hydrobromide drug variants containing D&C YELLOW NO. 10
| Company | Ingredient | NDC |
|---|---|---|
| CVS Pharmacy | guaifenesin, dextromethorphan hydrobromide | 69842-963 |
| >Company | >Ingredient | >NDC |
guaifenesin, dextromethorphan hydrobromide drug variants not containing D&C YELLOW NO. 10
| Company | Ingredient | NDC |
|---|---|---|
| No data available in table | ||
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSES
guaifenesin, dextromethorphan hydrobromide drug variants containing HYPROMELLOSES
| Company | Ingredient | NDC |
|---|---|---|
| CVS Pharmacy | guaifenesin, dextromethorphan hydrobromide | 69842-963 |
| >Company | >Ingredient | >NDC |
guaifenesin, dextromethorphan hydrobromide drug variants not containing HYPROMELLOSES
| Company | Ingredient | NDC |
|---|---|---|
| No data available in table | ||
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM HYDROXIDE
guaifenesin, dextromethorphan hydrobromide drug variants containing MAGNESIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| CVS Pharmacy | guaifenesin, dextromethorphan hydrobromide | 69842-963 |
| >Company | >Ingredient | >NDC |
guaifenesin, dextromethorphan hydrobromide drug variants not containing MAGNESIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| No data available in table | ||
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
guaifenesin, dextromethorphan hydrobromide drug variants containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| CVS Pharmacy | guaifenesin, dextromethorphan hydrobromide | 69842-963 |
| >Company | >Ingredient | >NDC |
guaifenesin, dextromethorphan hydrobromide drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| No data available in table | ||
| >Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
guaifenesin, dextromethorphan hydrobromide drug variants containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| CVS Pharmacy | guaifenesin, dextromethorphan hydrobromide | 69842-963 |
| >Company | >Ingredient | >NDC |
guaifenesin, dextromethorphan hydrobromide drug variants not containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| No data available in table | ||
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
NCE-1 Patent Challenge Dates 2025 - 2026
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
